Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice

Andrea Chiricozzi; Pasquale Comberiati; Enza D'Auria; Gianvincenzo Zuccotti; Diego G. Peroni

doi:10.1016/j.phrs.2020.104878

Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice

Andrea Chiricozzi, Pasquale Comberiati, Enza D'Auria, Gianvincenzo Zuccotti, Diego G. Peroni

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations. Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.

Lingua originale	English
pagine (da-a)	104878-N/A
Rivista	Pharmacological Research
Volume	158
DOI	https://doi.org/10.1016/j.phrs.2020.104878
Stato di pubblicazione	Pubblicato - 2020

Keywords

Atopic dermatitis
Children
Corticophobia
Corticosteroids
Pediatric
Side effects
Topical therapy

Accesso al documento

10.1016/j.phrs.2020.104878

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{42b072f01db14590aeb84952991b7eb9,

title = "Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice",

abstract = "Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations. Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.",

keywords = "Atopic dermatitis, Children, Corticophobia, Corticosteroids, Pediatric, Side effects, Topical therapy, Atopic dermatitis, Children, Corticophobia, Corticosteroids, Pediatric, Side effects, Topical therapy",

author = "Andrea Chiricozzi and Pasquale Comberiati and Enza D'Auria and Gianvincenzo Zuccotti and Peroni, {Diego G.}",

year = "2020",

doi = "10.1016/j.phrs.2020.104878",

language = "English",

volume = "158",

pages = "104878--N/A",

journal = "Pharmacological Research",

issn = "1043-6618",

publisher = "Attuale:ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: [email protected], [email protected], INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",

}

TY - JOUR

T1 - Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice

AU - Chiricozzi, Andrea

AU - Comberiati, Pasquale

AU - D'Auria, Enza

AU - Zuccotti, Gianvincenzo

AU - Peroni, Diego G.

PY - 2020

Y1 - 2020

N2 - Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations. Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.

AB - Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations. Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.

KW - Atopic dermatitis

KW - Children

KW - Corticophobia

KW - Corticosteroids

KW - Pediatric

KW - Side effects

KW - Topical therapy

KW - Atopic dermatitis

KW - Children

KW - Corticophobia

KW - Corticosteroids

KW - Pediatric

KW - Side effects

KW - Topical therapy

UR - http://hdl.handle.net/10807/213926

U2 - 10.1016/j.phrs.2020.104878

DO - 10.1016/j.phrs.2020.104878

M3 - Article

SN - 1043-6618

VL - 158

SP - 104878-N/A

JO - Pharmacological Research

JF - Pharmacological Research

ER -

Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo